EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

9 Months Ended

Dec. 31, 2016

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

2.EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings (Loss) Per Share

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):

	For the quarter ended				For the nine months ended
	December 31,				December 31,
	2016		2015		2016		2015
Basic earnings (loss) per share:
Net earnings (loss) from continuing operations	$	1,073	$	(439)	$	12,189	$	(6,966)
Net earnings (loss) from discontinued operations, net of tax		—		(971)		—		15,240
Net earnings (loss)	$	1,073	$	(1,410)	$	12,189	$	8,274
Basic weighted-average shares outstanding		77,507		77,831		77,475		77,903
Basic earnings (loss) per share:
Continuing operations	$	0.01	$	(0.01)	$	0.16	$	(0.09)
Discontinued operations		—		(0.01)		—		0.20
Net earnings (loss)	$	0.01	$	(0.02)	$	0.16	$	0.11
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding		77,507		77,831		77,475		77,903
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method		2,344		—		2,019		—
Diluted weighted-average shares outstanding		79,851		77,831		79,494		77,903
Diluted earnings (loss) per share:
Continuing operations	$	0.01	$	(0.01)	$	0.15	$	(0.09)
Discontinued operations		—		(0.01)		—		0.20
Net earnings (loss)	$	0.01	$	(0.02)	$	0.15	$	0.11

Due to the net loss from continuing operations incurred by the Company during the quarter and nine months ended December 31, 2015, the dilutive effect of options, warrants and restricted stock units covering 1.5 million and 1.4 million shares of common stock, respectively, was excluded in each period from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.

Additional options and warrants to purchase shares of common stock and restricted stock units, including performance-based restricted stock units not meeting performance criteria, that were outstanding during the periods presented but were not included in the computation of diluted earnings per share because the effect was anti-dilutive are shown below (in thousands, except share price amounts):

	For the quarter ended				For the nine months ended
	December 31,				December 31,
	2016		2015		2016		2015
Number of shares outstanding under options, warrants and restricted stock units		156		1,112		345		1,751
Range of exercise prices for options	$	32.85 -  $32.85	$	17.49 -  $62.06	$	20.27 -  $32.85	$	17.49 -  $62.06

Stockholders’ Equity

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded, most recently on July 28, 2016.  Under the modified common stock repurchase program, the Company may purchase up to $400.0 million of its common stock through the period ending June 30, 2018. During the nine months ended December 31, 2016, the Company repurchased 1.3 million shares of its common stock for $30.5 million.  Through December 31, 2016, the Company had repurchased 16.8 million shares of its stock for $285.7 million, leaving remaining capacity of $114.3 million under the stock repurchase program.

Accumulated Other Comprehensive Income

The following table presents the accumulated balances for each component of other comprehensive income (dollars in thousands):

	December 31,		March 31,
	2016		2016
Foreign currency translation	$	6,295	$	8,705
Unrealized gain (loss) on interest rate swap		2		(115)
	$	6,297	$	8,590